VAXX(VAXX)
VAXX
No analyst ratings available
No analyst price targets available for VAXX
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | — | — |
| Low | — | — |
| High | — | — |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | $-52M | $-52M |
| Low | $-52M | $-52M |
| High | $-52M | $-52M |
| EPS Avg | $-0.41 | $-0.41 |
| Low | $-0.41 | $-0.41 |
| High | $-0.41 | $-0.41 |
| Analysts (Rev / EPS) | — / 1 | — / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EBITDA Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| Net Income Avg | $-15M | $-46M | $-43M | $-48M | $-20M | $-20M | $-19M | $-20M |
| Low | $-15M | $-46M | $-43M | $-48M | $-20M | $-20M | $-19M | $-20M |
| High | $-15M | $-46M | $-43M | $-48M | $-20M | $-20M | $-19M | $-20M |
| EPS Avg | $-0.12 | $-0.36 | $-0.34 | $-0.38 | $-0.15 | $-0.16 | $-0.15 | $-0.15 |
| Low | $-0.12 | $-0.36 | $-0.34 | $-0.38 | $-0.15 | $-0.16 | $-0.15 | $-0.15 |
| High | $-0.12 | $-0.36 | $-0.34 | $-0.38 | $-0.15 | $-0.16 | $-0.15 | $-0.15 |
| Analysts (Rev / EPS) | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 |